CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist

British Journal of Pharmacology

Volumn 133, Issue 8, 2001, Pages 1405-1413

  Hasbak, Philip ^a   Sams, Anette ^b   Schifter, Søren ^a   Longmore, Jenny ^c   Edvinsson, Lars ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Adrenomedullin; Amylin; Calcitonin receptor like receptor; CGRP; Porcine coronary arteries; Receptor activity modifying proteins

Indexed keywords

4 (2 OXO 2,3 DIHYDROBENZOIMIDAZOL 1 YL)PIPERIDINE 1 CARBOXYLIC ACID [1 (3,5 DIBROMO 4 HYDROXYBENZYL) 2 OXO 2 (4 PHENYLPIPERAZIN 1 YL)ETHYL]AMIDE; ADRENOMEDULLIN; ALPHA CALCITONIN GENE RELATED PEPTIDE; AMYLIN; BETA CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; CARBOXYLIC ACID DERIVATIVE; MESSENGER RNA; RECEPTOR ACTIVITY MODIFYING PROTEIN; UNCLASSIFIED DRUG; WO 98 11128;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DILATATION; DRUG EFFECT; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEQUENCE HOMOLOGY; SWINE;

EID: 0034858770     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704210     Document Type: Article

References (57)

1. Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide
2. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products
3. Some quantitative uses of drug antagonists
4. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1
5. Characterization of binding sites for amylin, calcitonin, and CGRP in primate kidney
6. Adrenomedullin-(22-52) antagonizes vasodilator responses to CGRP but not adrenomedullin in the cat
7. Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37)
8. Comparative distribution of receptors for amylin and the related peptides calcitonin gene related peptide and calcitonin in rat and monkey brain
9. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product
10. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients
11. Comparative affinities of adrenomedullin (AM) and calcitonin gene-related peptide (CGRP) for [125I] AM and [125I] CGRP specific binding sites in porcine tissues
12. hCGR8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery
13. Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats
14. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
15. Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries
16. Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells
17. Molecular cloning and characterization of the porcine calcitonin gene-related peptide receptor
18. Clinical perspectives of calcitonin gene related peptide pharmacology
19. RAMPs: Accessory proteins for seven transmembrane domain receptors
20. Differential vasodilator profile of calcitonin gene-related peptide in porcine large and small diameter coronary artery rings
21. Calcitonin gene-related peptide (CGRP) in capsaicin-sensitive substance P-immunoreactive sensory neurons in animals and man: Distribution and release by capsaicin
22. Influence of CGRP (8-37), but not adrenomedullin (22-52), on the haemodynamic responses to lipopolysaccharide in conscious rats
23. Effects of prednisone and deflazacort on vertebral bone mass
24. Peptidergic innervation of human epicardial coronary arteries
25. Adrenomedullin, a multifunctional regulatory peptide
26. Decreased adrenomedullin production in the coronary circulation of patients with coronary artery disease
27. Islet amyloid and type 2 diabetes mellitus
28. The molecular pharmacology of CGRP and related peptide receptor subtypes
29. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells
30. Secretion of islet amyloid polypeptide in response to glucose
31. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells
32. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma
33. Adrenomedullin. Implications for hypertension research
34. Adrenomedullin decreases both cytosolic Ca2+ concentration and Ca(2+)- sensitivity in pig coronary arterial smooth muscle
35. Calcitonin gene-related peptide in patients with and without early reperfusion after acute myocardial infarction
36. Effects of two truncated forms of human calcitonin-gene related peptide: Implications for receptor classification
37. Plasma CGRP in acute myocardial infarction
38. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
39. Isolation and characterization of human calcitonin gene-related peptide
40. Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: Homologous peptides, separate receptors and overlapping biological actions
41. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats
42. The relaxant effect of adrenomedullin on particular smooth muscles despite a general expression of its mRNA in smooth muscle, endothelial and epithelial cells
43. Cardiovascular actions of adrenomedullin in conscious sheep
44. Innervation of human epicardial coronary veins: Immunohistochemistry and vasomotility
45. Central actions of adrenomedullin on cardiovascular parameters and sympathetic outflow in conscious rats
46. Expression of calcitonin receptor-like receptor and receptor-activity-modifying proteins in human cranial arteries
47. Recent advances in our understanding of peptide hormone receptors and RAMPs
48. Non-competitive antagonism of amylin on CGRP(1)-receptors in rat coronary small arteries
49. Endothelial cells actively synthesize and secrete adrenomedullin
50. Production and secretion of adrenomedullin from vascular smooth muscle cells: Augmented production by tumor necrosis factor-alpha
51. Transient vasodilatory effects of adrenomedullin on cerebral parenchymal microvessels in cats
52. Multiple receptors for calcitonin gene-related peptide and amylin on guineapig ileum and vas deferens
53. Effect of intravenous calcitonin gene related peptide on ischaemia threshold and coronary stenosis severity in humans
54. Limitations in using peptide drugs to characterize calcitonin gene-related peptide receptors
55. Pharmacological characterization of CGRP receptors mediating relaxation of the rat pulmonary artery and inhibition of twitch responses of the rat vas deferens
56. Receptors mediating CGRP-induced relaxation in the rat isolated thoracic aorta and porcine isolated coronary artery differentiated by halpha CGRP8 - 37
57. Effects of adrenomedullin and calcitonin gene-related peptide on contractions of the rat aorta and porcine coronary artery